Press Releases from Roots Analysis (285 total)
The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predi …
With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies are gradually progressing their…
The drug repurposing service providers market is estimated to be worth USD 1.2 b …
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities…
The global autoinjectors market is projected to grow at an annualized rate of ov …
Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and…
Growing at an annualized rate of over 16.5%, the cell therapy manufacturing mark …
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in…
With over 280 therapies under evaluation, the stem cell therapy market is estima …
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their…
The subcutaneous biologic drugs and affiliated technologies market is projected …
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving)…
The STING pathway targeting technologies market, featuring a healthy pipeline of …
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being…
The contract manufacturing market for Pharmaceuticals in China is estimated to b …
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business…
The Chinese biopharmaceutical contract manufacturing market is estimated to be w …
The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several…
Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in…
Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices…
Cell and Advanced Therapies Supply Chain Management Market, 2020-2030
The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and…
The Companion Diagnostics Development Services Market is estimated to be worth o …
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics…
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth US …
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development,…
The RNAi therapeutics market is anticipated to grow at an annualized rate of mor …
The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological…
The subcutaneous biologic drugs and affiliated technologies market is projected …
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving)…
The STING pathway targeting technologies market, featuring a healthy pipeline of …
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being…
The targeted protein degradation market is projected to grow at an annualized ra …
The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first…
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by …
In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, the US FDA…
The synthetic lethality-based drugs and targets market is estimated to be worth …
Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned…
The antibody contract manufacturing market is projected to reach USD 17 billion …
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase…
The fragment-based drug discovery market is estimated to be worth around USD 1.6 …
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering…
The global digital biomarkers market is projected to be worth over USD 22 billio …
Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pertinent applications, are…
The endocannabinoid system targeted therapeutics market is projected to be over …
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this…
The oligonucleotide synthesis, modification and purification services market is …
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of…
The nuclear medicine and radiopharmaceutical manufacturing market is estimated t …
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies…
The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, g …
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated…
The proteome profiling services market is projected to be worth USD 16 billion b …
Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on…
The global preventive vaccines market is projected to be worth USD 94 billion by …
Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still…
The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, …
Advances in the medical device industry have led to a substantial increase in developmental complexity, clinical trial conduct, and stringency of regulatory review, causing sponsors…
The next generation contact lenses and visual prostheses market is estimated to …
Recent technological advances in the field of ophthalmology and the availability of new biomaterials have substantially expanded the range of potential application areas of contact…
Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030, g …
Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been…
The contract fill / finish services market for biologics is anticipated to be wo …
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily…
Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract man …
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers
Roots Analysis is…
The next generation immune checkpoint inhibitors and stimulators market is estim …
Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions,…
The medical device label contract manufacturing market is projected to reach USD …
Outsourcing the manufacturing of labels is a popular trend among medical device developers, enabling such companies to leverage the advanced capabilities of CMOs, while focusing…
The STING pathway targeting technologies market, featuring a healthy pipeline of …
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being…
Growing at an annualized rate of over 35%, the large volume wearable injectors m …
Over the years, a rise in preference for self-administrable drugs / therapies has resulted in an increasing demand for user-friendly drug delivery solutions that are…
The Chinese biopharmaceutical contract manufacturing market is estimated to be w …
The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several…
The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2 …
Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional…
More than 45 encapsulated cell therapies and encapsulation technologies are bein …
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices…
Presently, over 160 innovative, software enabled systems are being used to effic …
The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and…
The Companion Diagnostics Development Services Market is estimated to be worth o …
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics…
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth US …
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development,…
The bispecific antibody therapeutics market is estimated to be worth USD 6.9 bil …
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm…
The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth …
Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models,…
The ophthalmic drugs contract manufacturing market is estimated to be worth USD …
Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and…
The peptides and macrocycle drug discovery services market is estimated to be wo …
Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery…
Peptide Therapeutics: Contract API manufacturing market is estimated to be worth …
Given the growing demand for peptide drugs and the complexities associated with their development and production, relying on the superior technical expertise and experience of…
The prefilled syringe fill / finish services market is estimated to is estimated …
The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination…
